These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6266318)

  • 1. A survey of x-ray diffraction studies of enzyme-other molecule interactions as possible models for receptor sites.
    Lipscomb WN
    Ann N Y Acad Sci; 1981; 367():326-39. PubMed ID: 6266318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypeptide hormone-receptor interactions: the structure and receptor binding of insulin and glucagon.
    Bedarkar S; Blundell TL; Dockerill S; Tickle IJ; Wood SP
    Ciba Found Symp; 1977; (60):105-21. PubMed ID: 215391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple conformational changes in enzyme catalysis.
    Hammes GG
    Biochemistry; 2002 Jul; 41(26):8221-8. PubMed ID: 12081470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition-state analogues in protein crystallography: probes of the structural source of enzyme catalysis.
    Lolis E; Petsko GA
    Annu Rev Biochem; 1990; 59():597-630. PubMed ID: 2197984
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct structural evidence for a concerted allosteric transition in Escherichia coli aspartate transcarbamoylase.
    Macol CP; Tsuruta H; Stec B; Kantrowitz ER
    Nat Struct Biol; 2001 May; 8(5):423-6. PubMed ID: 11323717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution.
    Stevens RC; Gouaux JE; Lipscomb WN
    Biochemistry; 1990 Aug; 29(33):7691-701. PubMed ID: 2271528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3.0-A resolution study of nucleotide complexes with aspartate carbamoyltransferase.
    Honzatko RB; Monaco HL; Lipscomb WN
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5105-9. PubMed ID: 388429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical interpretation of experiments on binding of peptide hormone to specific receptors by computer modelling.
    Peters F; Pingoud VA
    Biochim Biophys Acta; 1982 Feb; 714(3):442-7. PubMed ID: 6277387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allosteric activator Mg-ATP modifies the quaternary structure of the R-state of Escherichia coli aspartate transcarbamylase without altering the T<-->R equilibrium.
    Fetler L; Vachette P
    J Mol Biol; 2001 Jun; 309(3):817-32. PubMed ID: 11397099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of carbamoyl phosphate and succinate bound to aspartate carbamoyltransferase.
    Gouaux JE; Lipscomb WN
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4205-8. PubMed ID: 3380787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical limits in Scatchard analysis.
    Feldman HA
    J Biol Chem; 1983 Nov; 258(21):12865-7. PubMed ID: 6313679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray analysis of glucagon and its relationship to receptor binding.
    Sasaki K; Dockerill S; Adamiak DA; Tickle IJ; Blundell T
    Nature; 1975 Oct; 257(5529):751-7. PubMed ID: 171582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the allosteric mechanism of aspartate transcarbamoylase.
    Fetler L; Vachette P
    Nat Struct Biol; 2002 Feb; 9(2):87-9. PubMed ID: 11813011
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical studies of enzyme active sites.
    Sigman DS; Mooser G
    Annu Rev Biochem; 1975; 44():899-931. PubMed ID: 237464
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure of human urokinase plasminogen activator in complex with its receptor.
    Huai Q; Mazar AP; Kuo A; Parry GC; Shaw DE; Callahan J; Li Y; Yuan C; Bian C; Chen L; Furie B; Furie BC; Cines DB; Huang M
    Science; 2006 Feb; 311(5761):656-9. PubMed ID: 16456079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross quaternary changes in aspartate carbamoyltransferase are induced by the binding of N-(phosphonacetyl)-L-aspartate: A 3.5-A resolution study.
    Ladner JE; Kitchell JP; Honzatko RB; Ke HM; Volz KW; Kalb AJ; Ladner RC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3125-8. PubMed ID: 6954462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Receptor-enzyme interactions. Kinetic characteristics].
    Varfolomeev SD
    Biokhimiia; 1988 Oct; 53(10):1677-83. PubMed ID: 2852966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the trypsin-binding domain of Bowman-Birk type protease inhibitor and its interaction with trypsin.
    Tsunogae Y; Tanaka I; Yamane T; Kikkawa J; Ashida T; Ishikawa C; Watanabe K; Nakamura S; Takahashi K
    J Biochem; 1986 Dec; 100(6):1637-46. PubMed ID: 3032921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of active catalytic trimer of aspartate transcarbamoylase from proteolytically cleaved polypeptide chains.
    Powers VM; Yang YR; Fogli MJ; Schachman HK
    Protein Sci; 1993 Jun; 2(6):1001-12. PubMed ID: 8318885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulatory subunit of Escherichia coli aspartate carbamoyltransferase may influence homotropic cooperativity and heterotropic interactions by a direct interaction with the loop containing residues 230-245 of the catalytic chain.
    Newton CJ; Kantrowitz ER
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2309-13. PubMed ID: 2179954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.